Using blood pressure telemetry to assess acute changes in arterial stiffness in rats after nitric oxide synthase inhibition or environmental tobacco smoke exposure

Can J Physiol Pharmacol. 2010 Sep;88(9):918-28. doi: 10.1139/y10-066.

Abstract

Although environmental tobacco smoke (ETS) exposure has been reported to acutely increase arterial stiffness in humans, understanding of the underlying mechanisms is unclear and few studies have measured these effects in experimental animals. One potential mechanism for the increased arterial stiffness is reduced nitric oxide (NO) bioactivity as a result of oxidative stress. Thus, the objective of this study was to determine whether acute changes in arterial stiffness could be detected using arterial pulse wave dP/dt in blood pressure telemetry implanted rats and to investigate the role of NO in regulating dP/dt. Intravenous injection of acetylcholine (0.91 ng/kg) decreased and norepinephrine (0.02 mg/kg) increased dP/dt compared to saline vehicle (0.5 mL/kg). Injection of the NO synthase inhibitor, N(G)-nitro-L-arginine methyl ester (L-NAME; 30 mg/kg) decreased plasma nitrate/nitrite (NOx), but transiently increased dP/dt. ETS at low and high doses had no effect on dP/dt, but increased plasma NOx levels at high ETS exposure and increased plasma nitrotyrosine levels in both ETS groups. In conclusion, acute changes in NO production via acetylcholine or L-NAME alter the arterial pulse wave dP/dt consistently with the predicted changes in arterial stiffness. Although acute ETS appears to biologically inactivate NO, a concomitant increase in NO production at high ETS exposure may explain why dP/dt was not acutely altered by ETS in the current study.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arteries / drug effects
  • Arteries / physiology*
  • Blood Pressure / drug effects*
  • Blood Pressure Monitoring, Ambulatory / methods
  • Elasticity
  • Environmental Exposure
  • Enzyme Inhibitors / pharmacology*
  • Male
  • Nicotiana / adverse effects*
  • Nitrates / blood
  • Nitric Oxide Synthase Type III / antagonists & inhibitors*
  • Nitrites / blood
  • Oxidative Stress / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • Smoke / adverse effects*
  • Telemetry
  • Tyrosine / analogs & derivatives
  • Tyrosine / blood
  • Vasoconstrictor Agents / pharmacology
  • Vasodilator Agents / pharmacology

Substances

  • Enzyme Inhibitors
  • Nitrates
  • Nitrites
  • Smoke
  • Vasoconstrictor Agents
  • Vasodilator Agents
  • 3-nitrotyrosine
  • Tyrosine
  • Nitric Oxide Synthase Type III